Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com’s coverage highlights our seven biggest and most influential stories from the week’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else this weekend, make sure you’re still in the know with Massdevice +7.
7. Sen. Scott Brown stumps device tax at Covidien
Massachusetts Senator and GOP presidential hopeful Scott Brown spent time talking devices taxes and cutting steak with Covidien plc (NYSE:COV).
6. The CRM slump keeps on slumping
The cardiac rhythm management industry looks like it needs of a jolt of its own, stat. A look at earnings filed by two of the market’s biggest players, Boston Scientific (NYSE:BSX) and St. Jude Medical (NYSE:STJ), reveals that the slump is worse than some industry observers thought.
5. FDA guidance: Designing clinical studies for PMA submissions
The FDA took bold steps to outline expectations for medical device premarket submissions in the release of a new draft guidance that outlines the basic structure for clinical trials.
4. FDA releases new guidance on postmarket surveillance
The FDA is on a roll, releasing yet another draft guidance on medical device regulations this week, this time providing an overview of the postmarket surveillance program and procedural information on how companies should comply.
3. Stryker gets some love from "hedge fund king" Steven Cohen
Wall Street’s "hedge fund king" Stephen Cohen increased his holdings in Stryker Corp. (NYSE:SYK) during the second quarter by an astounding 1858 percent, bringing his stake to nearly 1.4 million shares.
2. Zimmer and Stryker poaching spat gets messy
Lawyers in a lawsuit filed by Stryker Corp. (NYSE:SYK) accusing Zimmer Holdings Inc. (NYSE:ZMH) of building its spine business on the back of Stryker’s scuffled over document disclosure deadlines, accusing each other of being "ludicrous," "frivolous," "premature" and guilty of "blatant gamesmanship." And that’s just what they put down on paper.
1. Medtronic’s former CEO Bill Hawkins one-on-one
In the first installment of an in-depth interview with Medtronic Inc.’s (NYSE:MDT) former CEO Bill Hawkins, he tells us that the company gave him a sword and he handed back the world.